Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$461K Sell
7,334
-400
-5% -$27.9K 0.02% 178
2025
Q4
$513K Buy
7,734
+400
+5% +$25.9K 0.03% 177
2025
Q3
$494K Hold
7,334
0.02% 187
2025
Q2
$640K Hold
7,334
0.03% 170
2025
Q1
$501K Hold
7,334
0.03% 177
2024
Q4
$570K Hold
7,334
0.03% 166
2024
Q3
$492K Sell
7,334
-3,666
-33% -$301K 0.02% 181
2024
Q2
$1.25M Hold
11,000
0.06% 113
2024
Q1
$1.53M Buy
+11,000
New +$1.38M 0.07% 107
2021
Q2
Sell
-4,288
Closed -$385K 259
2021
Q1
$385K Buy
4,288
+64
+2% +$6.01K 0.02% 223
2020
Q4
$390K Sell
4,224
-752
-15% -$67.1K 0.03% 217
2020
Q3
$513K Buy
+4,976
New +$520K 0.04% 183

Other funds holding DXCM

Bank of Hawaii's DXCM Position: Q1 2026 in Review

Bank of Hawaii reduced its DexCom (DXCM) stake by 5.2% in Q1 2026, selling an estimated $27.9K and leaving 7,334 shares worth $461K. The position accounts for 0.02% of the portfolio, ranked #178.

Bank of Hawaii first reported a position in DXCM in Q3 2020 and has held it in 12 quarters since. The position peaked at $1.53M in Q1 2024. 959 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • Bank of Hawaii held 7,334 shares of DexCom worth $461K as of Q1 2026.
  • Bank of Hawaii sold 400 DexCom shares in Q1 2026, an estimated $27.9K.
  • DexCom made up 0.02% of Bank of Hawaii's portfolio in Q1 2026, its #178 holding.
  • Bank of Hawaii first reported a position in DexCom in Q3 2020 and has held it in 12 quarters since.
  • Bank of Hawaii's DexCom position peaked at $1.53M in Q1 2024.
  • 959 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Bank of Hawaii's 13F filing for Q1 2026, filed 15 May 2026.